Tumor microvesicles contain retrotransposon elements and amplified oncogene sequences. Tumor cells release microvesicles containing proteins, RNAs, and DNA, reflecting the tumor's genetic status, including oncogene amplification. These microvesicles also carry high levels of retrotransposon RNA, such as LINE-1 and Alu elements, which can be transferred to normal cells. This expands the nucleic acid content of tumor microvesicles to include elevated levels of specific coding and non-coding RNA and DNA, mutated and amplified oncogene sequences, and transposable elements. Tumor microvesicles thus contain a repertoire of genetic information available for horizontal gene transfer and potential use as blood biomarkers for cancer. Tumor microvesicles are released by cancer cells and contain DNA, RNA, and proteins. They can carry amplified oncogenes like c-Myc, which is frequently amplified in medulloblastoma. Tumor microvesicles also contain high levels of retrotransposon RNA, including HERV, L1, and Alu elements, which may be transferred to normal cells. These findings suggest that tumor microvesicles can serve as a source of genetic information for horizontal gene transfer and as potential biomarkers for cancer. The study examined the nucleic acid content of microvesicles from various tumor types, including glioblastoma, medulloblastoma, and melanoma. Tumor microvesicles were found to contain elevated levels of c-Myc sequences, as well as retrotransposon RNA. These microvesicles were also enriched for retrotransposon elements, particularly HERV, which may be transferred to normal cells. The study also found that tumor microvesicles contain amplified genomic DNA, cDNA, and retrotransposon elements that may play a role in genetic communication between cells and serve as potential sources of tumor biomarkers. The study found that tumor microvesicles contain high levels of retrotransposon RNA, including HERV, L1, and Alu elements, which may be transferred to normal cells. These elements are enriched in tumor microvesicles and may contribute to genomic instability. The study also found that tumor microvesicles contain amplified oncogenes like c-Myc, which may be used as biomarkers for cancer. The findings suggest that tumor microvesicles can serve as a source of genetic information for horizontal gene transfer and as potential biomarkers for cancer.Tumor microvesicles contain retrotransposon elements and amplified oncogene sequences. Tumor cells release microvesicles containing proteins, RNAs, and DNA, reflecting the tumor's genetic status, including oncogene amplification. These microvesicles also carry high levels of retrotransposon RNA, such as LINE-1 and Alu elements, which can be transferred to normal cells. This expands the nucleic acid content of tumor microvesicles to include elevated levels of specific coding and non-coding RNA and DNA, mutated and amplified oncogene sequences, and transposable elements. Tumor microvesicles thus contain a repertoire of genetic information available for horizontal gene transfer and potential use as blood biomarkers for cancer. Tumor microvesicles are released by cancer cells and contain DNA, RNA, and proteins. They can carry amplified oncogenes like c-Myc, which is frequently amplified in medulloblastoma. Tumor microvesicles also contain high levels of retrotransposon RNA, including HERV, L1, and Alu elements, which may be transferred to normal cells. These findings suggest that tumor microvesicles can serve as a source of genetic information for horizontal gene transfer and as potential biomarkers for cancer. The study examined the nucleic acid content of microvesicles from various tumor types, including glioblastoma, medulloblastoma, and melanoma. Tumor microvesicles were found to contain elevated levels of c-Myc sequences, as well as retrotransposon RNA. These microvesicles were also enriched for retrotransposon elements, particularly HERV, which may be transferred to normal cells. The study also found that tumor microvesicles contain amplified genomic DNA, cDNA, and retrotransposon elements that may play a role in genetic communication between cells and serve as potential sources of tumor biomarkers. The study found that tumor microvesicles contain high levels of retrotransposon RNA, including HERV, L1, and Alu elements, which may be transferred to normal cells. These elements are enriched in tumor microvesicles and may contribute to genomic instability. The study also found that tumor microvesicles contain amplified oncogenes like c-Myc, which may be used as biomarkers for cancer. The findings suggest that tumor microvesicles can serve as a source of genetic information for horizontal gene transfer and as potential biomarkers for cancer.